Abcellera Net Income From Continuing Ops vs Income Tax Expense Analysis

ABCL Stock

USD 3.76 0.13 3.58%

Abcellera BiologicsInc financial indicator trend analysis is way more than just evaluating Abcellera BiologicsInc prevailing accounting drivers to predict future trends. We encourage investors to analyze account correlations over time for multiple indicators to determine whether Abcellera BiologicsInc is a good investment. Please check the relationship between Abcellera BiologicsInc Net Income From Continuing Ops and its Income Tax Expense accounts. Check out Trending Equities to better understand how to build diversified portfolios, which includes a position in Abcellera BiologicsInc. Also, note that the market value of any company could be tightly coupled with the direction of predictive economic indicators such as signals in main economic indicators.

For more information on how to buy Abcellera Stock please use our How to buy in Abcellera Stock guide.

Net Income From Continuing Ops vs Income Tax Expense

Net Income From Continuing Ops vs Income Tax Expense Correlation Analysis

The overlapping area represents the amount of trend that can be explained by analyzing historical patterns of Abcellera BiologicsInc Net Income From Continuing Ops account and Income Tax Expense. At this time, the significance of the direction appears to have almost identical trend.

The correlation between Abcellera BiologicsInc's Net Income From Continuing Ops and Income Tax Expense is 0.95. Overlapping area represents the amount of variation of Net Income From Continuing Ops that can explain the historical movement of Income Tax Expense in the same time period over historical financial statements of Abcellera BiologicsInc, assuming nothing else is changed. The correlation between historical values of Abcellera BiologicsInc's Net Income From Continuing Ops and Income Tax Expense is a relative statistical measure of the degree to which these accounts tend to move together. The correlation coefficient measures the extent to which Net Income From Continuing Ops of Abcellera BiologicsInc are associated (or correlated) with its Income Tax Expense. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when Income Tax Expense has no effect on the direction of Net Income From Continuing Ops i.e., Abcellera BiologicsInc's Net Income From Continuing Ops and Income Tax Expense go up and down completely randomly.

Correlation Coefficient

0.95

Relationship Direction	Positive
Relationship Strength	Very Strong

View All Relationships

Net Income From Continuing Ops

Income Tax Expense

Most indicators from Abcellera BiologicsInc's fundamental ratios are interrelated and interconnected. However, analyzing fundamental ratios indicators one by one will only give a small insight into Abcellera BiologicsInc current financial condition. On the other hand, looking into the entire matrix of fundamental ratios indicators, and analyzing their relationships over time can provide a more complete picture of the company financial strength now and in the future. Check out Trending Equities to better understand how to build diversified portfolios, which includes a position in Abcellera BiologicsInc. Also, note that the market value of any company could be tightly coupled with the direction of predictive economic indicators such as signals in main economic indicators.

For more information on how to buy Abcellera Stock please use our How to buy in Abcellera Stock guide.At this time, Abcellera BiologicsInc's Selling General Administrative is quite stable compared to the past year. Sales General And Administrative To Revenue is expected to rise to 1.68 this year, although the value of Tax Provision is projected to rise to (26.2 M).

	2021	2022	2023	2024 (projected)
Depreciation And Amortization	1.8M	59.7M	30.9M	20.4M
Interest Income	3.3M	16.1M	42.2M	44.4M

Depreciation And Amortization Interest Income

Abcellera BiologicsInc fundamental ratios Correlations

	Total Assets	Short Long Term Debt Total	Other Current Liab	Total Current Liabilities	Total Stockholder Equity	Other Liab	Net Tangible Assets	Property Plant And Equipment Net	Current Deferred Revenue	Net Debt	Retained Earnings	Accounts Payable	Cash	Non Current Assets Total	Long Term Debt	Cash And Short Term Investments	Net Receivables	Common Stock Total Equity	Common Stock Shares Outstanding	Non Current Liabilities Total	Other Current Assets	Other Stockholder Equity	Total Liab	Net Invested Capital	Property Plant And Equipment Gross	Short Long Term Debt
Total Assets		0.89	0.95	0.99	1.0	0.98	0.95	0.83	0.82	-0.69	0.96	0.99	0.79	0.97	0.96	1.0	0.71	0.99	0.83	0.98	0.79	0.78	0.99	1.0	0.82	-0.97
Short Long Term Debt Total	0.89		0.7	0.83	0.88	0.87	0.87	0.89	0.89	-0.33	0.95	0.86	0.46	0.96	0.81	0.87	0.3	0.82	0.71	0.94	0.87	0.85	0.91	0.88	0.89	-0.79
Other Current Liab	0.95	0.7		0.98	0.95	0.93	0.9	0.68	0.69	-0.84	0.85	0.95	0.9	0.86	0.95	0.96	0.89	0.98	0.79	0.88	0.62	0.64	0.93	0.96	0.68	-0.98
Total Current Liabilities	0.99	0.83	0.98		0.99	0.98	0.94	0.78	0.78	-0.75	0.93	0.99	0.84	0.94	0.97	0.99	0.79	0.99	0.82	0.95	0.73	0.74	0.98	0.99	0.78	-0.99
Total Stockholder Equity	1.0	0.88	0.95	0.99		0.98	0.95	0.82	0.82	-0.7	0.96	0.99	0.8	0.97	0.96	1.0	0.71	0.99	0.83	0.97	0.79	0.77	0.99	1.0	0.82	-0.98
Other Liab	0.98	0.87	0.93	0.98	0.98		0.92	0.8	0.77	-0.66	0.94	0.98	0.75	0.97	0.95	0.97	0.69	0.97	0.83	0.98	0.73	0.75	0.99	0.98	0.79	-0.94
Net Tangible Assets	0.95	0.87	0.9	0.94	0.95	0.92		0.93	0.93	-0.54	0.91	0.93	0.65	0.94	0.89	0.95	0.65	0.93	0.79	0.94	0.73	0.91	0.95	0.95	0.93	-0.97
Property Plant And Equipment Net	0.83	0.89	0.68	0.78	0.82	0.8	0.93		0.99	-0.21	0.84	0.79	0.34	0.89	0.73	0.81	0.35	0.76	0.68	0.88	0.71	0.99	0.85	0.82	1.0	-0.81
Current Deferred Revenue	0.82	0.89	0.69	0.78	0.82	0.77	0.93	0.99		-0.23	0.83	0.77	0.36	0.88	0.74	0.81	0.36	0.77	0.65	0.85	0.72	0.99	0.83	0.82	0.99	-0.82
Net Debt	-0.69	-0.33	-0.84	-0.75	-0.7	-0.66	-0.54	-0.21	-0.23		-0.58	-0.73	-0.99	-0.51	-0.73	-0.72	-0.91	-0.75	-0.59	-0.55	-0.44	-0.14	-0.63	-0.7	-0.2	0.74
Retained Earnings	0.96	0.95	0.85	0.93	0.96	0.94	0.91	0.84	0.83	-0.58		0.97	0.69	0.96	0.88	0.96	0.53	0.91	0.82	0.96	0.91	0.78	0.96	0.96	0.83	-0.9
Accounts Payable	0.99	0.86	0.95	0.99	0.99	0.98	0.93	0.79	0.77	-0.73	0.97		0.82	0.94	0.94	0.99	0.72	0.97	0.84	0.96	0.81	0.73	0.98	0.99	0.78	-0.96
Cash	0.79	0.46	0.9	0.84	0.8	0.75	0.65	0.34	0.36	-0.99	0.69	0.82		0.62	0.81	0.81	0.91	0.83	0.67	0.66	0.54	0.28	0.74	0.8	0.34	-0.82
Non Current Assets Total	0.97	0.96	0.86	0.94	0.97	0.97	0.94	0.89	0.88	-0.51	0.96	0.94	0.62		0.92	0.96	0.54	0.94	0.79	0.99	0.79	0.85	0.98	0.96	0.89	-0.91
Long Term Debt	0.96	0.81	0.95	0.97	0.96	0.95	0.89	0.73	0.74	-0.73	0.88	0.94	0.81	0.92		0.96	0.76	0.98	0.67	0.93	0.67	0.69	0.95	0.96	0.73	-0.94
Cash And Short Term Investments	1.0	0.87	0.96	0.99	1.0	0.97	0.95	0.81	0.81	-0.72	0.96	0.99	0.81	0.96	0.96		0.72	0.99	0.83	0.96	0.8	0.76	0.99	1.0	0.8	-0.98
Net Receivables	0.71	0.3	0.89	0.79	0.71	0.69	0.65	0.35	0.36	-0.91	0.53	0.72	0.91	0.54	0.76	0.72		0.79	0.59	0.58	0.26	0.32	0.67	0.72	0.35	-0.81
Common Stock Total Equity	0.99	0.82	0.98	0.99	0.99	0.97	0.93	0.76	0.77	-0.75	0.91	0.97	0.83	0.94	0.98	0.99	0.79		0.8	0.95	0.7	0.72	0.98	0.99	0.76	-0.98
Common Stock Shares Outstanding	0.83	0.71	0.79	0.82	0.83	0.83	0.79	0.68	0.65	-0.59	0.82	0.84	0.67	0.79	0.67	0.83	0.59	0.8		0.81	0.68	0.64	0.82	0.82	0.68	-0.8
Non Current Liabilities Total	0.98	0.94	0.88	0.95	0.97	0.98	0.94	0.88	0.85	-0.55	0.96	0.96	0.66	0.99	0.93	0.96	0.58	0.95	0.81		0.78	0.83	0.99	0.97	0.87	-0.92
Other Current Assets	0.79	0.87	0.62	0.73	0.79	0.73	0.73	0.71	0.72	-0.44	0.91	0.81	0.54	0.79	0.67	0.8	0.26	0.7	0.68	0.78		0.63	0.77	0.79	0.7	-0.7
Other Stockholder Equity	0.78	0.85	0.64	0.74	0.77	0.75	0.91	0.99	0.99	-0.14	0.78	0.73	0.28	0.85	0.69	0.76	0.32	0.72	0.64	0.83	0.63		0.8	0.77	0.99	-0.77
Total Liab	0.99	0.91	0.93	0.98	0.99	0.99	0.95	0.85	0.83	-0.63	0.96	0.98	0.74	0.98	0.95	0.99	0.67	0.98	0.82	0.99	0.77	0.8		0.99	0.85	-0.96
Net Invested Capital	1.0	0.88	0.96	0.99	1.0	0.98	0.95	0.82	0.82	-0.7	0.96	0.99	0.8	0.96	0.96	1.0	0.72	0.99	0.82	0.97	0.79	0.77	0.99		0.82	-0.98
Property Plant And Equipment Gross	0.82	0.89	0.68	0.78	0.82	0.79	0.93	1.0	0.99	-0.2	0.83	0.78	0.34	0.89	0.73	0.8	0.35	0.76	0.68	0.87	0.7	0.99	0.85	0.82		-0.81
Short Long Term Debt	-0.97	-0.79	-0.98	-0.99	-0.98	-0.94	-0.97	-0.81	-0.82	0.74	-0.9	-0.96	-0.82	-0.91	-0.94	-0.98	-0.81	-0.98	-0.8	-0.92	-0.7	-0.77	-0.96	-0.98	-0.81

Click cells to compare fundamentals

Abcellera BiologicsInc Account Relationship Matchups

Abcellera BiologicsInc fundamental ratios Accounts

	2019	2020	2021	2022	2023	2024 (projected)
Total Assets	23.5M	1.0B	1.3B	1.5B	1.5B	989.6M
Short Long Term Debt Total	6.9M	6.1M	36.4M	82.3M	77.4M	39.0M
Other Current Liab	129.3K	76.7M	77.5M	58.0M	61.3M	50.2M
Total Current Liabilities	7.9M	103.5M	120.7M	118.3M	119.0M	87.2M
Total Stockholder Equity	10.3M	830.5M	1.0B	1.2B	1.2B	781.7M
Other Liab	1.3M	65.6M	134.0M	112.6M	129.5M	69.6M
Net Tangible Assets	2.7M	683.9M	829.5M	1.1B	1.2B	1.3B
Property Plant And Equipment Net	8.5M	17.9M	111.6M	217.3M	287.7M	302.1M
Current Deferred Revenue	3.2M	6.6M	7.5M	21.6M	26.1M	27.4M
Net Debt	(661.9K)	(588.0M)	(439.7M)	(304.3M)	(55.9M)	(58.7M)
Retained Earnings	(4.7M)	114.2M	267.7M	426.2M	279.8M	198.1M
Accounts Payable	1.6M	20.0M	32.0M	33.2M	25.5M	20.9M
Cash	7.6M	594.1M	476.1M	386.5M	133.3M	126.7M
Non Current Assets Total	10.8M	192.2M	388.8M	515.4M	616.1M	317.1M
Cash And Short Term Investments	7.6M	594.1M	723.0M	886.5M	760.6M	546.7M
Net Receivables	4.4M	213.2M	160.6M	38.6M	64.4M	89.0M
Common Stock Total Equity	5.1M	710.4M	722.4M	734.4M	844.5M	479.0M
Common Stock Shares Outstanding	154.1M	269.5M	318.3M	314.8M	289.2M	290.3M
Liabilities And Stockholders Equity	23.5M	1.0B	1.3B	1.5B	1.5B	989.6M
Non Current Liabilities Total	5.3M	71.5M	172.2M	189.3M	216.8M	120.7M
Capital Lease Obligations	3.1M	3.7M	36.4M	82.3M	77.4M	81.2M
Other Current Assets	1.8M	6.0M	21.2M	75.4M	20.9M	23.1M
Other Stockholder Equity	2.3M	5.9M	35.4M	74.1M	121.1M	127.1M
Total Liab	13.2M	175.0M	292.8M	307.6M	335.8M	208.0M
Net Invested Capital	6.5M	832.9M	1.0B	1.2B	1.2B	780.7M
Property Plant And Equipment Gross	8.5M	17.9M	121.4M	235.7M	318.3M	334.2M
Total Current Assets	12.6M	813.3M	929.8M	1.0B	872.0M	672.5M
Capital Stock	12.7M	710.4M	722.4M	734.4M	753.2M	540.0M
Net Working Capital	4.7M	709.8M	809.1M	907.2M	753.0M	585.3M
Short Term Debt	2.9M	190K	3.7M	5.6M	6.2M	3.9M
Common Stock	5.1M	710.4M	722.4M	734.4M	753.2M	537.3M
Property Plant Equipment	8.5M	17.9M	111.6M	217.3M	249.8M	262.3M

Abcellera BiologicsInc Investors Sentiment

The influence of Abcellera BiologicsInc's investor sentiment on the probability of its price appreciation or decline could be a good factor in your decision-making process regarding taking a position in Abcellera. The overall investor sentiment generally increases the direction of a stock movement in a one-year investment horizon. However, the impact of investor sentiment on the entire stock market does not have solid backing from leading economists and market statisticians.

Investor biases related to Abcellera BiologicsInc's public news can be used to forecast risks associated with an investment in Abcellera. The trend in average sentiment can be used to explain how an investor holding Abcellera can time the market purely based on public headlines and social activities around Abcellera BiologicsInc. Please note that most equities that are difficult to arbitrage are affected by market sentiment the most.

Abcellera BiologicsInc's market sentiment shows the aggregated news analyzed to detect positive and negative mentions from the text and comments. The data is normalized to provide daily scores for Abcellera BiologicsInc's and other traded tickers. The bigger the bubble, the more accurate is the estimated score. Higher bars for a given day show more participation in the average Abcellera BiologicsInc's news discussions. The higher the estimated score, the more favorable is the investor's outlook on Abcellera BiologicsInc.

Some investors attempt to determine whether the market's mood is bullish or bearish by monitoring changes in market sentiment. Unlike more traditional methods such as technical analysis, investor sentiment usually refers to the aggregate attitude towards Abcellera BiologicsInc in the overall investment community. So, suppose investors can accurately measure the market's sentiment. In that case, they can use it for their benefit. For example, some tools to gauge market sentiment could be utilized using contrarian indexes, Abcellera BiologicsInc's short interest history, or implied volatility extrapolated from Abcellera BiologicsInc options trading.

Pair Trading with Abcellera BiologicsInc

One of the main advantages of trading using pair correlations is that every trade hedges away some risk. Because there are two separate transactions required, even if Abcellera BiologicsInc position performs unexpectedly, the other equity can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Abcellera BiologicsInc will appreciate offsetting losses from the drop in the long position's value.

Moving against Abcellera Stock

0.72	ACB	Aurora Cannabis Sell-off Trend	Pair Corr
0.7	CGC	Canopy Growth Corp Financial Report 27th of June 2024	Pair Corr
0.66	ELYM	Eliem Therapeutics Upward Rally	Pair Corr
0.65	HCWB	HCW Biologics	Pair Corr
0.62	KRYS	Krystal Biotech Financial Report 13th of May 2024	Pair Corr

The ability to find closely correlated positions to Abcellera BiologicsInc could be a great tool in your tax-loss harvesting strategies, allowing investors a quick way to find a similar-enough asset to replace Abcellera BiologicsInc when you sell it. If you don't do this, your portfolio allocation will be skewed against your target asset allocation. So, investors can't just sell and buy back Abcellera BiologicsInc - that would be a violation of the tax code under the "wash sale" rule, and this is why you need to find a similar enough asset and use the proceeds from selling Abcellera BiologicsInc to buy it.

The correlation of Abcellera BiologicsInc is a statistical measure of how it moves in relation to other instruments. This measure is expressed in what is known as the correlation coefficient, which ranges between -1 and +1. A perfect positive correlation (i.e., a correlation coefficient of +1) implies that as Abcellera BiologicsInc moves, either up or down, the other security will move in the same direction. Alternatively, perfect negative correlation means that if Abcellera BiologicsInc moves in either direction, the perfectly negatively correlated security will move in the opposite direction. If the correlation is 0, the equities are not correlated; they are entirely random. A correlation greater than 0.8 is generally described as strong, whereas a correlation less than 0.5 is generally considered weak.

Correlation analysis and pair trading evaluation for Abcellera BiologicsInc can also be used as hedging techniques within a particular sector or industry or even over random equities to generate a better risk-adjusted return on your portfolios.

Pair Correlation Correlation Matching

When determining whether Abcellera BiologicsInc is a strong investment it is important to analyze Abcellera BiologicsInc's competitive position within its industry, examining market share, product or service uniqueness, and competitive advantages. Beyond financials and market position, potential investors should also consider broader economic conditions, industry trends, and any regulatory or geopolitical factors that may impact Abcellera BiologicsInc's future performance. For an informed investment choice regarding Abcellera Stock, refer to the following important reports:

How To Invest In Abcellera

Details

Is Abcellera Stock a good investment?

Details

What is Abcellera BiologicsInc's Net Worth?

Details

Largest Biotechnology Companies

View

Largest Pharmaceuticals, Biotechnology & Life Sciences Companies

View

Check out Trending Equities to better understand how to build diversified portfolios, which includes a position in Abcellera BiologicsInc. Also, note that the market value of any company could be tightly coupled with the direction of predictive economic indicators such as signals in main economic indicators.

For more information on how to buy Abcellera Stock please use our How to buy in Abcellera Stock guide.

Note that the Abcellera BiologicsInc information on this page should be used as a complementary analysis to other Abcellera BiologicsInc's statistical models used to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the ETFs module to find actively traded Exchange Traded Funds (ETF) from around the world.

Complementary Tools for Abcellera Stock analysis

When running Abcellera BiologicsInc's price analysis, check to measure Abcellera BiologicsInc's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Abcellera BiologicsInc is operating at the current time. Most of Abcellera BiologicsInc's value examination focuses on studying past and present price action to predict the probability of Abcellera BiologicsInc's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Abcellera BiologicsInc's price. Additionally, you may evaluate how the addition of Abcellera BiologicsInc to your portfolios can decrease your overall portfolio volatility.

	Latest Portfolios Quick portfolio dashboard that showcases your latest portfolios
	Portfolio Analyzer Portfolio analysis module that provides access to portfolio diagnostics and optimization engine
	Funds Screener Find actively-traded funds from around the world traded on over 30 global exchanges
	Commodity Channel Use Commodity Channel Index to analyze current equity momentum
	Pair Correlation Compare performance and examine fundamental relationship between any two equity instruments
	FinTech Suite Use AI to screen and filter profitable investment opportunities
	Economic Indicators Top statistical indicators that provide insights into how an economy is performing
	Bollinger Bands Use Bollinger Bands indicator to analyze target price for a given investing horizon
	Equity Valuation Check real value of public entities based on technical and fundamental data
	Efficient Frontier Plot and analyze your portfolio and positions against risk-return landscape of the market.
	Global Correlations Find global opportunities by holding instruments from different markets
	USA ETFs Find actively traded Exchange Traded Funds (ETF) in USA
	Portfolio Center All portfolio management and optimization tools to improve performance of your portfolios

Is Abcellera BiologicsInc's industry expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of Abcellera BiologicsInc. If investors know Abcellera will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about Abcellera BiologicsInc listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.

Quarterly Earnings Growth

0.459

Earnings Share

(0.51)

Revenue Per Share

0.131

Quarterly Revenue Growth

(0.57)

Return On Assets

(0.1)

The market value of Abcellera BiologicsInc is measured differently than its book value, which is the value of Abcellera that is recorded on the company's balance sheet. Investors also form their own opinion of Abcellera BiologicsInc's value that differs from its market value or its book value, called intrinsic value, which is Abcellera BiologicsInc's true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because Abcellera BiologicsInc's market value can be influenced by many factors that don't directly affect Abcellera BiologicsInc's underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.

Please note, there is a significant difference between Abcellera BiologicsInc's value and its price as these two are different measures arrived at by different means. Investors typically determine if Abcellera BiologicsInc is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, Abcellera BiologicsInc's price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.

Macroaxis helps investors of all levels and skills to maximize the upside of all their holdings and minimize the risk associated with market volatility, economic swings, and company-specific events. View terms and conditions

Feedback Blog

Made with optimal in San Francisco

2024 Macroaxis LLC

Abcellera Net Income From Continuing Ops vs Income Tax Expense Analysis

Net Income From Continuing Ops vs Income Tax Expense

Net Income From Continuing Ops vs Income Tax Expense Correlation Analysis

Correlation Coefficient

Net Income From Continuing Ops

Income Tax Expense

Abcellera BiologicsInc fundamental ratios Correlations

Abcellera BiologicsInc Account Relationship Matchups

High Positive Relationship

High Negative Relationship

Abcellera BiologicsInc fundamental ratios Accounts

Abcellera BiologicsInc Investors Sentiment

Pair Trading with Abcellera BiologicsInc

Moving against Abcellera Stock

Complementary Tools for Abcellera Stock analysis

COMMON DESTINATIONS

MAIN CATEGORIES

COMPANY

Total Stockholder Equity	+ 1.0	Total Assets
Cash And Short Term Investments	+ 1.0	Total Assets
Net Invested Capital	+ 1.0	Total Assets
Cash And Short Term Investments	+ 1.0	Total Stockholder Equity
Net Invested Capital	+ 1.0	Total Stockholder Equity
Property Plant And Equipment Gross	+ 1.0	Property Plant And Equipment Net

Cash	- 0.99	Net Debt
Short Long Term Debt	- 0.99	Total Current Liabilities
Short Long Term Debt	- 0.98	Net Invested Capital
Short Long Term Debt	- 0.98	Common Stock Total Equity
Short Long Term Debt	- 0.98	Cash And Short Term Investments
Short Long Term Debt	- 0.98	Total Stockholder Equity